Teva appoints Matthew Shields as EVP Global Operations; Eric Drapé departs after 11 years

TEVA PHARMACEUTICAL INDUSTRIES LTD

Matthew Shields becomes EVP Global Operations effective June 3, 2024, based in Parsippany, NJ.
Shields previously SVP Manufacturing at Merck Animal Health; prior roles at Sanofi and Amgen.
Initial base salary of $825,000 with 100% target annual cash incentive, equity awards, and $200,000 sign-on cash.
Eric Drapé leaves Teva after 11 years, including over 4 years as EVP Global Operations.
Shields reports directly to CEO Richard Francis as part of the Pivot to Growth strategy.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Eric Drapé

Executive Vice President, Global Operations

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2024-06-03
Successor: Matthew Shields
Filed: May 15, 2024, 7:59 PM ET

Mr. Eric Drapé, Executive Vice President, Global Operations, will be leaving Teva Pharmaceutical Industries Ltd.

Appointed

Matthew Shields

Executive Vice President, Global Operations

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2024-06-03
Filed: May 15, 2024, 7:59 PM ET

Mr. Matthew Shields has been appointed as Executive Vice President, Global Operations of Teva and a member of Teva Executive Management, effective June 3, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Drapé departed as Executive Vice President, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: will be leaving
Role: Executive Vice President, Global Operations

Exact text from the filing

Mr. Eric Drapé, Executive Vice President, Global Operations, will be leaving Teva Pharmaceutical Industries Ltd.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Shields was appointed as Executive Vice President, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: appointed
Role: Executive Vice President, Global Operations

Exact text from the filing

Mr. Matthew Shields has been appointed as Executive Vice President, Global Operations of Teva and a member of Teva Executive Management, effective June 3, 2024.

View on SEC.gov

TEVA PHARMACEUTICAL INDUSTRIES LTD filing history →

Source: SEC EDGAR

accession 0001193125-24-138936

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.